NCT02184299View on ClinicalTrials.gov

Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

January 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

DRUG

Prednisone

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184299 - Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients | Biotech Hunter | Biotech Hunter